
Strand Life Sciences is hoping for a bigger seat at the table in the U.S. next-generation sequencing (NGS) market with the launch of an expanded version of its Stranddvantage pan-cancer genomic profiling test.

Strand Life Sciences is hoping for a bigger seat at the table in the U.S. next-generation sequencing (NGS) market with the launch of an expanded version of its Stranddvantage pan-cancer genomic profiling test.

Revolution LLC plans to raise $450 million for its next fund, according to a filing with the Securities and Exchange Commission.
The raise comes right as the previous fund — which backs growth-stage companies and was also valued at $450 million — is reaching its limit for initial investments. D.C.-based Revolution has invested in 11 companies from that fund since its 2011 inception, with one or two more new investments expected.

BioMarker Strategies, LLC, today announced the appointment of Samuel Broder, M.D., as Chairman of its Scientific Advisory Board and his election as a member of the Company’s Board of Directors, effective immediately.
“We are privileged to bring a leader of Dr. Broder’s distinction and scientific experience back to our Company. His record of accomplishment in internal medicine and oncology are well known, and we look forward to benefiting from his scientific and strategic insight in the years ahead,” said Jerry Parrott, President and CEO, BioMarker Strategies. “I am particularly pleased that Dr. Broder has agreed to take on the important role of Chairman of our Scientific Advisory Board. We expect to announce the members of our newly constituted SAB in the near future.”

Awards recognize best practices in university-based economic development
The University Economic Development Association (UEDA) is currently seeking applications for its annual Awards of Excellence program, which recognizes cutting edge university-based economic development initiatives from across the country. The Awards of Excellence Program spotlights higher education institutions and their partners who are transforming their campuses and communities into engines of economic prosperity through creative initiatives in five categories:
![]()
The Emerging Leaders (EL) Program provides rising leaders with the skills and connections essential to professional success and effective community leadership. Through eight monthly interactive sessions, participants will gain unique exposure to the issues, resources and key players impacting Montgomery County, while strengthening their professional skill sets.
If you experience any difficulty creating an account or filling out the application, please contact Carol Ippolito carol.ippoito@leadermont.org or 301-881-3333

Technology Digest Inc., an information technology consulting and product development firm, has made its new home at Johns Hopkins University Montgomery County Campus.
The firm is the brainchild of Sarah Iranpour, a first-generation immigrant to the United States from Iran. Iranpour spent years working for others in the IT field. When her son went to college, she decided to “go after my dream developing something substantial for health and medical.”

In the 21st century, health care innovation is happening at lightning speed. From the mapping of the human genome to the rise of personalized medicines that are linked to advances in molecular medicine, we have seen constant breakthroughs that are changing the face of disease treatment, management, and cures. Health research is moving quickly, but the federal drug and device approval apparatus is in many ways the relic of another era. We have dedicated scientists and bold leaders at agencies like the NIH and the FDA, but when our laws don’t keep pace with innovation, we all lose.
If we want to save more lives and keep this country the leader in medical innovation, we have to make sure there’s not a major gap between the science of cures and the way we regulate these therapies.

Boston-based venture capital firm SV Life Sciences is working on its sixth fund, with a fundraising target of $400 million, according to a Form D filing on the U.S. Securities and Exchange Commission’s website. The firm invests in biotech, medical devices, health IT and healthcare services.

New Enterprise Associates is planing on making a $5 million investment in Speedinvest’s newly launched second fund. NEA is anticipating that it will provide $50 million in follow-on funding for Speedinvest’s portfolio companies. Speedinvest’s second fund will focus on backing European startups.

Johns Hopkins University’s Applied Physics Laboratory has been the hidden mastermind behind some of the nation’s most influential technologies for 73 years.
Now the Howard County institution is going deeper into the medical world, while maintaining its foothold in national security and space exploration projects.